The Hydrogen-Bonding System in Deuterated Copper Fluorosilicate Tetrahydrate: a Neutron Diffraction Study

In CuSiF₆.4D₂O, chains of SiF₆ and Cu(D₂O)₄F₂ octahedra are linked by hydrogen bonds to form a three-dimensional structure.

La₃(Si₂O₇)Cl₃

The structure of La₃(Si₂O₇)Cl₃ is built up from [La₂Cl₂Si₂O₆] sheets stacked along the b direction with [LaClO] units accommodated between adjacent sheets.

Nd₄V₅Si₄O₂₂

Nd₄V₅Si₄O₂₂ has a quasi-two-dimensional chevkinite-type structure, consisting of rutile-like vanadium–oxygen layers with V—V distances of 2.794(2)Å.

The Binary Hafnium Phosphide Hf₃P₂

Hf₃P₂ has an anti-Sb₂S₃-type structure in which singly capped and bicapped trigonal Hf₆P prisms are interconnected via common edges and faces to form a three-dimensional network.

Tricaesium Ditellurium Tetravanadium Chloride Tetradecaoxide

The structure of (CsCl)Cs₂(TeV₂O₇)₂ consists of stacks of [V₂TeO₇] sheets alternately separated by layers of Cs atoms and layers of Cs and Cl atoms.

Rietveld Refinement of the Orthorhombic Pbca Structures of Rb₂CdSi₅O₁₂, Cs₂MnSi₅O₁₂, Cs₂CoSi₅O₁₂ , and Cs₂NiSi₅O₁₂ Leucites by Synchrotron X-ray Powder Diffraction

The Pbca structures of four leucite analogues have been refined by the Rietveld method using high-resolution synchrotron X-ray powder diffraction patterns collected on stations 2.3 and 9.1 of the Daresbury Synchrotron Radiation Source.

Sodium Dinitritobis(pyrazine-2-carboxylato-N,O)cobaltate(III)

Benzyltri­chloro(1,10-phenanthroline-N,N')tin(IV) Benzene Solvate (1/1)

Bis(di­ethylammonium) Tetra­chlorodi­vinylstannate(IV)

A 3:1 Disordered Solid Solution of Di-μ-methoxo-O:O-bis­[trimethoxooxomolybdenum(VI)] and Di-μ-methoxo-O:O-bis­[chlorodimethoxooxomolybdenum(VI)]

The AsF₆⁻ Salt of a 1,2-Di­thia-4-azolylium Cation with Sterically Demanding Substituents

Bis[methyl N^β-(4-di­methylamino­phenylmethylene)di­thiocarbazato]nickel(II)

1,4-Di­methylpyridinium Bis(6,7-di­hydro-5H-1,4-dithiepine-2,3-di­thiolato-S,S')cuprate(III)

trans-Di­chloro­tetra­kis­(pyridine-N)molybdenum(III) Tribromide

Tris(N,N-di­ethyldi­thiocarbamato-S,S')(thio­nitrosyl-N)molybdenum(III), [Mo(η²-S₂CNEt₂)₃(NS)]

(4-Chloro­benzene­thiolato-S)(η⁵-cyclo­pentadienyl)(tri­phenylphosphine-P)nickel(II)

An Mo₂(CO)₄ (Mo Mo) Fragment Stabilized by a Tripod Ligand

trans-Di­azidobis[1,2-bis­(di­ethylphosphino)ethane-P,P']iron(II)

Copper(II) and Nickel(II) Complexes with 3,14-Di­methyl-2,6,13,17-tetra­azatri­cyclo[16.4.0.0^7,12]do­cosane, [M(C₂₀H₄₀N₄)]Cl₂.2H₂O (M = Cu^II and Ni^II)

Di­iodobis(η⁵-tri­methylsilylcyclo­pentadienyl)titanium(IV)

Tetra­kis­(2,3,5,6-tetra­methylpyrazinium) Tetra-μ₃-iodo-hexa-μ-iodo-dodeca­iodohexa­antimonate(4–) Tetrahydrate

A Condensed Dialkoxide Complex of Copper(II), [(CH₃)₂NCH₂CH₂N(CH₃)₂]Cu[{OC(CF₃)₂}₂O]

catena-Poly[{di-μ-nitrato-1:2κ⁴O-bis­[(tri­phenylphosphine-P)copper(I)]}-μ-4,4'-bi­pyridyl-N:N'] Tetra­hydro­furan Solvate

(Cyclo­hexylamine-N){2-[(2-thio­phenyl)imino­methyl]phenolato-O,N,S}nickel(II)

[N-(2-Amino-κN-ethyl)piperaziniumyl-N¹]tetra­chloroindium(III)

Bis(p-amino­benzoic acid-N)di­chlorocadmium(II)

Caesium 2-(2-Hy­droxy-5,5-di­methyl-1,3-dioxo-2-cyclo­hexyl)-5,5-di­methyl-1,3-cyclo­hexanedionato(1–) Monohydrate

Bis[bis­(2-pyridyl-N) sulfide]palladium(II) Bis(tetra­fluoroborate)

Bis(nitrato-O,O')bis­{2-[2-(2-thienyl)ethynyl]pyridine-N}cobalt(II)

Bis[1,2-bis­(di­phenylphosphino)ethane-P,P']chloroosmium(II) Hexa­fluorophosphate Di­chloro­methane Solvate

1-(R)-{2-[1-(R)-(N,N-Di­methylamino)ethyl]-1,1'-(S,S)-biferrocen-2'-yl}ethyl-N,N-di­methylammonium Tri­chloro(di­methyl sulfoxide-S)platinate(II)

Monosodium 4-Amino-1-hy­droxy-1,1-butanediyldi­phosphonate Trihydrate (Alendronate)

Bis(acetato-O)bis­(pyridine-N)palladium(II) Monohydrate and Bis(acetato-O)bis­(di­ethylamine-N)palladium(II)

Aqua[bis­(salicyl­idene)ethylenediaminato](iso­butyl)cobalt(III)

Di­butyl 2,6-Di­methyl-4-(3-nitro­phenyl)-1,4-di­hydro­pyridine-3,5-di­carboxylate, Diiso­butyl 2,6-Di­methyl-4-(3-nitro­phenyl)-1,4-di­hydro­pyridine-3,5-di­carboxylate and Di-tert-butyl 2,6-Di­methyl-4-(3-nitro­phenyl)-1,4-di­hydro­pyridine-3,5-di­carboxylate

(E)-6-Chloro-3-[2-(4-chloro­phenylsulfonyl)ethenyl]-4-chromanone, (E)-6-Bromo-3-[2-(4-bromo­phenylsulfonyl)ethenyl]-4-chromanone and (E)-3-[2-(4-Chloro­phenylsulfonyl)ethenyl]-6-meth­oxy-4-chromanone

Tri­methyl[2-(2-methyl-2-propenoyl­oxy)ethyl]ammonium Iodide (Methacryloylcholine Iodide)

Crystalline Complexes Involving Amino Acids. II. (R)-(−)-1-Phenylglycinium Hydrogen Squarate Monohydrate

Redetermination of 1,7-Di­phenyl-1,7-dicarba-closo-dodecaborane(12)

1-Diiso­propylphosphino-2-phenyl-1,2-dicarba-closo-dodecaborane(12)

cis-2-sec-Butyl-4-{4-[4-(4-{[2-(2,4-di­chloro­phenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]meth­oxy}phenyl)-1-piperazinyl]phenyl}-2,4-di­hydro-3H-1,2,4-triazol-3-one (Itraconazole)

Lupulin D

Substituted Imidazonaphthyridine Derivatives. I. C₁₉H₁₄F₃N₃, C₁₈H₁₀F₅N₃, C₁₈H₁₁ClF₃N₃ and C₁₈H₁₁BrF₃N₃

Substituted Imidazonaphthyridine Derivatives. II. C₁₉H₁₇N₃O and C₂₄H₁₉N₃O

Substituted Imidazonaphthyridine Derivatives. III. C₂₄H₂₈N₄, C₂₄H₂₈N₄O and C₂₃H₂₅BrN₄

Tris(4-chloro­phenyl)phosphine and Tris(4-fluoro­phenyl)phosphine

N,N,N',N'-Tetra­methylethylenedi­ammonium Di­hydrogendiphosphate Dihydrate

Tris(1,4-butanediyldi­ammonium) Bis(cyclotriphosphate) Tetrahydrate

1,6-Hexanedi­ammonium cyclo-Hexaphosphate Hexahydrate

A Di­hydrooxazinone

A Fully Cyclo-Substituted Cyclo­hexane

2-(6-Meth­oxy-7-methyl-1,2,3,4-tetra­hydro-1-naphthyl)ethyl 4,7,7-tri­methyl-3-oxo-2-oxabi­cyclo[2.2.1]heptane-1-carboxylate

A Fluorinated D-Homoestrone Derivative

Anticancer and Antifertility Agents. II. N,N'-Hexa­methylenebis(3-pyridinecarboxamide)

17α-Ethynyl-19-nor-3-oxo-4-androsten-17β-yl Acetate (Norethindrone Acetate)

Tri­phenylpropargylphosphonium Bromide

Glycyl-L-histidinium Chloride Dihydrate: an Unusual Histidine Conformation

Half-Chair Conformation of trans-1,4-Di­methyl-7,7-di­phenylbi­cyclo[4.1.0]hepta-2,5-dione

(1E,3Z,5E)-2,5-Di­aza-1,6-bis­(di­methylamino)-1,3,5-hexatriene-3,4-dicarbo­nitrile

Coumurrayin

The Charge-Transfer Complex 4-(2-Hydroxyethyl)carbazole–2,3-Di­chloro-5,6-di­cyano-1,4-benzo­quinone (1/1) (HEK–DDQ)

β-Cyclodextrin Nonanoic Acid 1:1 Complex

1-(4-Chloro­phenyl)-3a-methyl-5-phenyl-3a,4-di­hydro-1,2,4-oxa­diazolo[4,5-a][1,5]benzodiazepine

2,4,6-Tri-O-benzyl-myo-inositol

Methyl 6-O-[(R)-1-Carboxyethyl]-α-D-galacto­pyranoside

21-Acet­oxy-16α-propion­oxy-11β,17α-di­hydroxypregna-1,4-diene-3,20-dione Monohydrate

(R_S)-4-p-Toluene­sulfinylcyclohexa-1,4-diene­carboxylic Acid Ethyl Ester

A New Conformationally Restricted Aspartic Acid Analogue with a Bi­cyclo[2.2.2]octane Skeleton

[3-(4-Methylphenyl)-5-isoxazolyl]aceto­nitrile

Bis[5,5-bis­(4-methoxyphenyl)-3,3-di­methyl-2-tetra­hydro­furanyl] Ether

2,10-Di­chloro-6-(2,4-di­methylphen­oxy)dibenzo[d,g][1,3,6,2]dioxa­thia­phosphocine 6-Sulfide

4-(5-Methyl-1,3,4-oxa­diazol-2-yl)-1,3-phenylene Di­acetate

4,4'-Bis(2,4,6-tri­methylbenzenesulfonamido)di­phenylmethane

Di­ethyl 5-Bis(di­phenylphosphinoyl)methyl-2-hy­droxy-3-tert-butylphenylphosphonate Hydrate at 173K

Iso­propylamidinium Chloride

Diiso­propylammonium Bromide

A Substituted cis,trans,cis,cis-[4.5.5.5]Fenestrene

3a,7a-Di­bromo-2-butyl-4,7-methano-1,3,3a,4,7,7a-hexa­hydro-2H-iso­indole-1,3-dione from the Reaction of 3,4-Di­bromo-1-butylmale­imide with Cyclo­pentadiene

5,15-Di­aza-6,16-di­hydroxytetrabenzo[b,e,k,n]perylene

4-(4-Chloro­phenyl)-2,6-di­phenyl-(4H)-pyran-3,5-dicarbaldehyde

Bi­phenyl-3-carboxylic Acid at 296 and 203K

N-Saccharinperacetic Acid Monohydrate and N-Saccharinpentanoic Acid Monohydrate

Ammonium Salts of Phosphoglycolic Acid (H₃PG): NH₄. H₂PG, 3NH₄. H₂PG. HPG, 2NH₄. HPG and 3NH₄.PG.H₂O at 150K

4-Amino-1-(2-de­oxy-β-D-ribo­furanosyl)-6,7-di­hydro-1H,5H-cyclo­penta­pyrimidine-2-one

(E)-2,2,5,5-Tetra­methyl-3,4-bis­[4-(tri­bromo­methyl)phenyl]hex-3-ene

Racemic α,α'-o-Xylylene-1,1'-bis­[(3,5-di­methyl-5,6-di­hydro-1,3,5-triazine-6-spiro-9'-fluorene)-2,4(1H,3H)-dione]

Packing of Four Independent Molecules: 1-Methyl-N,N'-bis­(salicyl­idene)-2,4-phenylenedi­amine

O-Acetyl-N-(o-hydroxybenzyl)-N-iso­propylhydroxylamine

3-Hydroxyanthranilic Acid Hydrochloride

9,10,12,14-Tetra­hydro-12,12,14,14-tetra­phenyl-9,10[3',4']-furanoanthracene

C₂₀H₁₀F₈, a Di­vinyl Acetylene

1,3,5-Tri-tert-butyl-5-(1,3,5-tri-tert-butyl-4-oxo-2,5-cyclohexadienyl)methylbi­cyclo[4.1.0]hept-3-en-2-one, a Highly Hindered Propane

Structures of the Diels–Alder Reaction Products of Thymo­quinone and 1-Vinylcyclohexene. III. 5-Iso­propyl-2-methyltri­cyclo[8.4.0.0^2,7]tetradeca-4,9-diene-3,6-dione, C₁₈H₂₄O₂

Methyl 2,7,7-Tri­methyl-4-(3-nitro­phenyl)-5-oxo-1,4,5,6,7,8-hexa­hydro­quinoline-3-carboxylate and 3-Acetyl-2,7,7-tri­methyl-4-phenyl-1,4,5,6,7,8-hexa­hydro-5-quinolone

The Anhydrous Racemate of the Carcinostatic Agent Cyclophosphamide and the Bicyclic Degradation Product 1-(2-Chloro­ethyl)tetra­hydro-1H,5H-1,3,2-di­aza­phospholo[2,1-b][1,3,2]oxaza­phosphorine 9-Oxide

Coumarin 338

Structural Studies of Mitomycins. VIII. Mitomycin D Hydrate, C₁₅H₁₈N₄O₅.1.5H₂O

Acetone 4,4-Di­methyl-5-oxo-2-pyrazolin-3-ylhydrazone

Racemic 3,6-Di­methyl-3,6-bis­(tert-butyldi­methylsilyl­oxy)-1,7-cyclododecadiyne

2-Carb­oxy- and 2,7-Di­carb­oxy-4,5-benzotropone: Hydrogen-Bonding Patterns of a β-Keto Acid and a Related β-Keto 1,5-Diacid

Biological Activity of 4-(4-Bromo­phenyl)thiosemicarbazide

New Editor-in-Chief of IUCr journals